Continued drug dependence treatment for people locked down in housing estates is important. But people not currently in treatment also need support.
Academic rigour, journalistic flair
Articles on Opioids
Displaying 61 - 80 of 161 articles
New rules attempt to curb opioid-related deaths in Australia. These changes are a step in the right direction – but we need to tread carefully to avoid unintended consequences.
The overdose crisis — coupled with a lack of accessible harm reduction services — represents a growing concern for young queer and trans men who use drugs.
The crisis has made recovery more difficult for those with substance use disorders. The inability to get to support group meetings, stress and illness are just some of the factors.
A new report counts the social costs of pharmaceutical opioid misuse and illegal opioid use in Australia for 2015/2016. The numbers are fairly grim.
Pharmacists are well positioned to provide communities with a lifesaving drug.
Taking tranquilizers with opioids increases the risk of overdose tenfold.
Aggressive marketing of prescription opioids by pharmaceutical companies provided doctors with scant information about potential harmful effects.
Urgently needed treatment for opioid use disorder is often denied to incarcerated people, feeding the crisis in prisons and jails.
Fentanyl has been a prime culprit in the opioid crisis in the United States. It’s now turning up in cocaine and methamphetamine in New South Wales.
In 2016, drug misuse was cited as the top concern among New Hampshire voters. What remedies are the Democratic primary contenders putting forward to combat the opioid crisis?
From colonial poppy fields to pharmatrash, southern Africa offers a fascinating history of drug regimes – one that helps us make sense of drug policies and legislation today.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Opioid overdoses killed 47,000 Americans in 2017 — more than gun violence. Many fewer would have died if they’d been treated with the life-saving drug naloxone, also called Narcan.
Artificial intelligence holds great promise for medicine, but safeguards are needed to ensure it does not harm patients.
While critics accuse companies facing lots of lawsuits of using bankruptcy as a sort of ‘get of jail free card,’ the reality of the legal procedure is more complicated.
Previously secret documents and data make it clear that many companies engaged in the distribution of prescription painkillers either skirted or ignored their legal obligations for years.
State governments are leading the charge against opioid makers over their role in the epidemic. A team of researchers at Penn State examined just how much the crisis has cost them.
With the opioid crisis there is no doubt that physicians need safer, nonaddictive pain killers. Now new insights on how to create these are coming from an unlikely source: the naked mole rat.
In the midst of a public health crisis, with increasing rates of death from opioid overdose, the Ontario government is clawing back life-saving measures.
Top contributors
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Professor, Institute for Musculoskeletal Health, University of Sydney
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Professor, Sydney School of Public Health, University of Sydney
-
Professor of Neuropharmacology, University of Central Lancashire
-
Associate Professor of Sociology, Bentley University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor of Geography, Penn State
-
Head of Alcohol and other Drug Research, Centre for Population Health; Burnet Principal for Alcohol, other drugs and harm reduction, Burnet Institute
-
Senior Lecturer in Criminology, UNSW Sydney
-
Associate Professor of Population Health, New York University
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Associate Professor, Mental Health and Addiction, Rural Health Research Institute, Charles Sturt University
-
PhD Candidate, National Drug and Alcohol Research Centre, UNSW Sydney
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
